The FDA unveiled its Compounding Quality Center of Excellence, a new initiative to help drug outsourcing facilities meet quality standards.
The center will offer training beginning in March and will host a conference in the fall on best practices. It will also conduct research on key issues faced by outsourcing facilities.
The in-person training will target registered outsourcing facilities and, as space allows, pharmacies that are considering becoming outsourcing facilities, the agency said.
“By providing comprehensive, accessible learning tools, we will support outsourcing facilities in reliably producing high-quality compounded products that meet FDA’s standards,” said CDER Director Janet Woodcock.